BERKELEY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:QUCY) doing business as Quantum Cyber (the "Company" or "Quantum Cyber"), today announced a strategic update in response to the Trump Administration's newly released National Cybersecurity Strategy, outlining the Company's positioning within the rapidly evolving quantum and cyber defense landscape. The Company also disclosed the pre-funding of the second  tranche pursuant to a previously announced private placement with lead shareholder David Lazar. Aligning With the Trump Administration's National Cybersecurity Strategy On March 10, 2026, the White House released a sweeping National Cybersecurity Strategy doc

BERKELEY, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:QUCY) doing business as Quantum Cyber, today announced, effective upon the commencement of trading on March 12, 2026 (U.S. Eastern Time), it officially changed its ticker symbol to "QUCY" on the Nasdaq Capital Market. Further the Company's name will change to Quantum Cyber N.V. ("Quantum" or "Company") effective with a general meeting of shareholders planned for April 2026. The corporate name change and stock ticker symbol change reflect the Company's business strategy and better reflect the future operations, which will include a shift toward quantum computing and cybersecurity-oriented offerings. Forward-Loo

8-K - MAINZ BIOMED N.V. (0001874252) (Filer)

10-K - MAINZ BIOMED N.V. (0001874252) (Filer)

DEF 14A - MAINZ BIOMED N.V. (0001874252) (Filer)

8-K - MAINZ BIOMED N.V. (0001874252) (Filer)

8-K - MAINZ BIOMED N.V. (0001874252) (Filer)